ipsapirone has been researched along with Depression, Involutional in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goodman, M; Grossman, R; Mitropoulou, V; New, A; Reynolds, D; Schmeidler, J; Siever, LJ; Silverman, J | 1 |
Bakish, D; Bologa, M; Kroft, C; Lam, R; Lapierre, YD; Payeur, R; Plamondon, J; Reesal, RT; Remick, RA; Rosales, D; Saxena, B; Silverstone, P; Turner, P; Vincent, PM | 1 |
2 trial(s) available for ipsapirone and Depression, Involutional
Article | Year |
---|---|
Efficacy of open-label venlafaxine in subjects with major depressive disorder: associations with neuroendocrine response to serotonergic and noradrenergic probes.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Second-Generation; Clonidine; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Norepinephrine; Personality Inventory; Pyrimidines; Serotonin; Serotonin Receptor Agonists; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
A Canadian multicenter study of three fixed doses of controlled-release ipsapirone in outpatients with moderate to severe major depression.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Canada; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Pyrimidines; Serotonin Receptor Agonists; Treatment Outcome | 1998 |